LaCAR MDx at BeSHG/NVHG 2026
In 2026, the Dutch and Belgian societies for human genetics join forces for a cross-border meeting in the heart of Rotterdam - bringing together the clinical geneticists, laboratory scientists and researchers who put genetic testing to work in daily practice.
For a Belgian company, this one is close to home in every sense.
Why we'll be there
LaCAR MDx is a Belgian company that develops, manufactures and commercialises CE-IVD genetic diagnostic kits under ISO 13485, from our site at the Liège Science Park.
What we'll be showing:
- Pharmacogenetics: TPMT, DPD, CYP2C9, CYP2C19 and NUDT15, for laboratories implementing pre-treatment genotyping
- Genetic predispositions and disorders: genetic thrombosis (Factor II, Factor V Leiden, MTHFR, PAI-1), HLA-B27, hemochromatosis, food intolerance
- Newborn screening by qPCR: SCID, SMA and XLA, in a single duplex workflow
- GeneFox: result interpretation, clinician validation and LIS transfer, in the browser
Come and talk to us about
- Bringing pharmacogenetic testing into routine clinical practice
- Running a genetic testing menu without changing your existing PCR platform
- Traceable, clinician-validated result interpretation with GeneFox
Meet the team
Dorian Chiboub (sales manager)
Book a meeting
Tell us what you'd like to discuss and we'll reserve a slot with the team.
Conference website: nvhg.nl